Study links telomere length to risk of death from COVID-19
WHO strongly recommends antiviral drug for patients with non-severe COVID-19
21 April 2022Stricter COVID measures associated with negative mental health effects, lower opinion of government’s pandemic response
22 April 2022Study links telomere length to risk of death from COVID-19
New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April), suggests that shorter telomeres, a feature of aging, may influence the severity of COVID-19 and the risk of dying from the disease, particularly in women. The study is by Dr. Ana Virseda-Berdices, María Ángeles Jiménez-Sousa and Amanda Fernández-Rodríguez from the Health Institute Carlos III, Madrid, Spain and colleagues.
